|
Dr. Miller received a Ph.D. in biophysics from UCLA and UC Santa Cruz in 1976. He . earned a law degree and focused his intellectual property practice in biotechnology. Following a partnership at Seed & Berry in Seattle, he joined NeoRx in 1987 as an executive officer and served as responsible executive for all aspects of FDA approval and commercialization of NeoRx's first product. Nine years later he joined Ostex International as chief strategy officer followed by two years as CEO of Reprogen, a functional genomics company. For the next five years Dr. Miller served as senior vice president of aQuantive, Inc. an internet technology company. Presently, Dr. Miller is on the board of directors of Koronis Pharmaceuticals, AmKor Pharma, Tissue Repair Company and CEO of Neurotherapeutics Pharma. Dr. Miller's career achievements include obtaining the first US patent for an animal on behalf of the University of Washington, structuring and negotiating numerous multimillion dollar technology license agreements, and managing legal aspects of more than $250M in private and public debt and equity transactions. | 